FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

QS Problems Seen in French Catheter Manufacturer

[ Price : $8.95]

FDA warns Prince Medical about Quality System and Medical Device Reporting violations in its French diagnostic catheter manufactur...

Data Lacking on Animal Antibiotic Use

[ Price : $8.95]

The New York Times says that scientists seeking greater restrictions on antibiotic use in food animals are concerned about the lac...

Are FDA Trial Designs Ready for Cell-based Therapies?

[ Price : $8.95]

A university researcher questions whether the current FDA-recommended placebo-controlled clinical trial process is a good fit for ...

Democratic Platform Silent on FDA

[ Price : $8.95]

The Democratic 2012 platform is silent on any changes to be made to FDA.

Lilly Releases Glucagon Mobile App

[ Price : $8.95]

Lilly Diabetes releases a free app for Glucagon users and their support network.

Budget Sequestration Projected to Cut $300 Million at FDA

[ Price : $8.95]

The Alliance for a Stronger FDA projects 2013 budget cuts under Congress sequestration could deliver a devastating blow to FDA and...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Boukhari Prince Medical BPM, Commed, DPT Lakewood, Infupharma, Merge Healthcare,...

Orphan Drug Act Evolves with FDA Changes: Attorneys

[ Price : $8.95]

A client alert from Washington, DC-based attorneys highlights evolving FDA policy developments under the Orphan Drug Act.

Violations Found in DPT Lakewood Inspection

[ Price : $8.95]

FDAs New Jersey District Office warns DPT Lakewood about CGMP violations in its manufacturing of Santyl ointment.

R&D Costs Up, Results Down: Study

[ Price : $8.95]

GBI Research says that companies are spending more on research and development but have fewer new products to show for it.